Depth Filtration Market Growth and Analysis, Industry Trends, Size, Shares, Forecast

The Global Depth Filtration Market is poised to reach USD 2.96 Billion by 2022 from USD 1.70 Billion in 2017, at a CAGR of 11.7%.

Browse 71 market data Tables and 29 Figures spread through 127 Pages and in-depth TOC on “Depth Filtration Market”

http://www.marketsandmarkets.com/Market-Reports/depth-filtration-market-143876285.html

The report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

The growth in this market will majorly be driven by the increasing production of biologics and large molecules, as depth filtration plays a significant role in providing pure and quality products. Depth filters offer advantages such as low cost and ease of use; these advantages are driving their uptake in the market. However, low capacity of depth filters for high-density harvest is a key challenge in this market.

Speak To Analyst:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=143876285

Furthermore, based on application, the depth filtration market is categorized into final product processing, cell clarification, raw material filtration, and other applications. In 2017, final product processing segment is expected to account the largest share of the global depth filtration market. The final product processing segmented is further divided into small molecule processing and biologics processing. The large share of the final product processing segment is attributed to the rapid growth in the biopharmaceutical industry, expansion in generics production, and the need for high-quality final products.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global depth filtration market in 2017, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR in the forecast period. Significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence are the major factors fueling the growth of the depth filtration market in the Asia-Pacific region.

Download PDF Brochure@http://www.marketsandmarkets.com/pdfdownload.asp?id=143876285

The depth filtration market is dominated by established players such as Merck KGaA (Germany), Sartorius Stedim Biotech S.A. (France), and Pall Corporation (U.S.).

Oxygen Therapy Equipment Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

The Oxygen Therapy Equipment Market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022.

According to a new market research report “Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) — Global Forecast to 2022”, published by MarketsandMarkets™.

Browse 148 market data tables and 46 figures spread through 175 pages and in-depth TOC on “Oxygen Therapy Equipment Market”

http://www.marketsandmarkets.com/Market-Reports/oxygen-therapy-equipment-market-118828572.html

Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.

Oxygen source equipment is expected to dominate the market in 2017

On the basis of products, the Oxygen Therapy Equipment Market is segmented into oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is expected to dominate the global Oxygen Therapy Equipment Market in 2017. The increasing incidence of respiratory disorders and technological advancements to develop smaller, quieter and more effective equipment are key drivers increasing the demand for oxygen source equipment.

Download PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=118828572

Stationary oxygen therapy devices are estimated to command the largest market share in 2017

The Oxygen Therapy Equipment Market is segmented by portability into stationary devices and portable devices. In 2017, the stationary devices segment is expected to account for the largest share of the Oxygen Therapy Equipment Market, by portability. Severe complications in patients suffering from respiratory disorders and the increasing proportion of geriatric population across the globe are major drivers for the growth of this segment.

North America to account for the major market share in 2017

Based on region, the Oxygen Therapy Equipment Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the Oxygen Therapy Equipment Market in 2017 on account of the increasing proportion of the geriatric population, rising number of hospitals, and increasing awareness regarding oxygen therapy.

Talk To Our Research Analysts:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=118828572

Key players in the Oxygen Therapy Equipment Market include Philips Healthcare (Netherlands), Linde Healthcare (Germany), Chart Industries, Inc. (U.S.), Invacare Corporation (U.S.), Becton, Dickinson and Company (U.S.), Smiths Medical (U.S.), Drägerwerk AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Taiyo Nippon Sanso Corporation (Japan),

Pen Needles Market Growth Opportunity and Industry Forecast

The Pen Needles Market is expected to reach USD 2.81 Billion will be growing at a CAGR of 11.2%.

According to the new market research report “Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) — Trends & Global Forecasts to 2021”, published by MarketsandMarkets™. 

Don’t miss out on business opportunities in Pen Needles Market.

Speak to our analyst and gain crucial industry insights that will help your business grow:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=75948613

A number of factors such as the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and needle anxiety; growing diabetic population; and conferences, meetings, and congresses to create pen needle awareness are expected to drive the growth of the Pen Needles Market during the forecast period.

In this report, the Pen Needles Market is segmented on the basis of type, needle length, therapy, mode of purchase, and region. Based on type, the Pen Needles Market is categorized into standard pen needles and safety pen needles. The standard pen needles segment is expected to account for the largest share of the Pen Needles Market in 2016. However, the safety pen needles segment is projected to grow at a higher CAGR during the forecast period.

Browse and in-depth TOC on “Pen Needles Market”

102 — Tables

53 — Figures

185 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html

Based on needle length, the Pen Needles Market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm needle length segment is expected to account for the largest share of the market in 2016. However, the 4mm needle length segment is expected to grow at the highest CAGR during the forecast period.

On the basis of therapy, the Pen Needles Market is segmented insulin therapy, growth hormone therapy, and Glucagon-like Peptide-1 (GLP-1) therapy. The insulin therapy segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.

Based on mode of purchase, the Pen Needles Market is segmented into retail and non-retail purchase. The retail purchase segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR during the forecast period.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613

Geographically, the global Pen Needles Market is divided into North America, Europe, Asia, and the Rest of the World (Latin America, Pacific countries, the Middle East, and Africa). Europe is expected to account for the largest share of the Pen Needles Market in 2016, followed by North America, Asia, and the Rest of the World. The Asian market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering pen needle products

Prominent players in the global Pen Needles Market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Cell Lysis Market Analysis 2018 Globally by Key Manufacturers, Countries, Type, Application and Forecast

The Global Cell Lysis Market is expected to reach USD 3.84 Billion, at a CAGR of 10.3%.

According to the new market research report “Cell Lysis Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) — Global Forecasts to 2021”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Cell Lysis Market.

The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Lysis Market along with the estimates and forecasts of the revenue and market share analysis.

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=260138321

The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine

The report segments this market based on product, type of cell, end-users, and regions. Among the various product, the consumables segment is expected to account for the largest share of the market. The consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Enzymes segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of enzymes segment can be attributed to the increasing investments for cell-based research.

Browse and in-depth TOC on “Cell Lysis Market”

84 — Tables

41 — Figures

135 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/cell-lysis-market-260138321.html

On the basis of type of cell, the Cell Lysis Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global Cell Lysis Market in 2016. Rising aging population and increasing need for development of new cell therapies are the key factors propelling the growth of this market.

End-users, included in the Cell Lysis Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the global Cell Lysis Market in 2016. High incidence of diseases and research investments in life sciences is driving the growth of this market.

Request for Free Sample Report @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321

Based on regions, the global Cell Lysis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing government funding in North America.

Key players in the Cell Lysis Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Medical Automation Market 2018 Analysis, Key Players, Size, Growth Rate and Forecast

The Global Medical Automation Market over the forecast period expected to reach USD 55.03 Billion, at CAGR of 9.5 %.

According to the new market research report “Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) — Global Forecast to 2020”, published by MarketsandMarkets™.

On the basis of application, the medical automation market is divided into four major segments, namely, diagnostic and monitoring automation (automated imaging, automated image analysis, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistics automation and trainers). The therapeutic automation segment is estimated to hold the largest share of the global medical automation market in 2015. Increasing application of automated devices (such as defibrillators, surgical robots, surgical navigation systems, and automated medication systems) in therapeutics and rising incidences of various chronic diseases are driving the growth of this market segment.

Browse and in-depth TOC on “Medical Automation Market”

92 — Tables

53 — Figures

194 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html

On the basis of end users, the global medical automation market is divided into four segments, namely, hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

A number of factors such as rising government support for medical automation, growing need for reproducibility and accuracy during medical procedures, investments by venture capitalists and collaborations to promote automated medical devices, and technological advancements are fueling the demand for automation in the healthcare industry. Additionally, increasing use of automation in various research activities, rising cost of labor, and rising number of research studies in emerging nations are some other factors contributing to the growth of the medical automation market. On the other hand, stringency of regulatory procedures leading to delay in product launches and high cost of automated solutions are the key factors hampering the growth of the global medical automation market.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsampleNew.asp?id=848

North America is estimated to hold the largest share of the global medical automation market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 11.6% from 2015 to 2020. Presence of a large geriatric population; increasing prevalence of CVDs, diabetes, and cancer; rising number of clinical research activities; and growing government expenditure on healthcare and life sciences research are propelling the growth of the Asia-Pacific medical automation market.

Koninklijke Philips N.V. (Netherlands), Siemens AG, (Germany), General Electric Company (U.S.), Medtronic plc. (U.S.), Tecan Group Ltd. (Switzerland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Regenerative Medicine Market Size, Share, Growth, Trend and Forecast

[137 Pages Report] The Regenerative Medicine Market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6%. 

The cell-based products are expected to dominate the global Regenerative Medicine Market.

Don’t miss out on business opportunities in Regenerative Medicine Market.

Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=65442579

The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.

Browse and in-depth TOC on “Regenerative Medicine Market”

87 — Tables

38 — Figures

137 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html

Based on therapy, the Regenerative Medicine Market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. The cell therapy segment is expected to account for the largest share of this market, increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.

By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=65442579

Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.

Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Rehabilitation Equipment Market Analysis 2018 Globally by Key Manufacturers, Countries, Type, Application and Forecast

The global Rehabilitation Equipment Market is expected to reach 14.91 Billion by 2021 from USD 9.86 Billion in 2016, at a CAGR of 8.6% during the forecast period.

According to the new market research report “Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecasts to 2021”, published by MarketsandMarkets™.

Don’t miss out on business opportunities in Rehabilitation Equipment Market.

This Research Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=194775519

The growth of this market is mainly driven by factors such as growing incidence of disabilities resulting from non-communicable diseases, favorable healthcare reforms, and rapid growth in the geriatric population coupled with the rising prevalence of chronic diseases. However, a high cost & maintenance expense of rehabilitation equipment is the key factor that is expected to restrain the growth of this market to a certain extent.

In this report, the Rehabilitation Equipment Market has been segmented on the basis of type, application, end user, and region. Based on the type, the Rehabilitation Equipment Market is segmented into mobility equipment, body support devices, exercise equipment, and daily living aids. In 2016, the daily living aids segment accounted for the largest share of the market.

Browse and in-depth TOC on “Rehabilitation Equipment Market”

154 — Tables

31 — Figures

162 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/rehabilitation-equipment-market-194775519.html

On the basis of end user, the Rehabilitation Equipment Market is segmented into hospitals & clinics, rehabilitation centers, physiotherapy centers, and home care settings. In 2016, the hospitals & clinics segment accounted for the largest share of the Rehabilitation Equipment Market. This can be attributed to factors such as higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments, increasing sports injuries, the growth of the disabled and aged populations, and supportive reimbursement policies for hospital treatment.

Based on region, the Rehabilitation Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, Europe dominated the market, followed by North America. Factors such as supportive government initiatives for safe patient handling, growth in geriatric population, and the presence of a large number of players in Europe are driving the growth of the European Rehabilitation Equipment Market.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=194775519

The Rehabilitation Equipment Market is fragmented in nature with several big and emerging players. This market is dominated by key players such as Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (U.S.), and HEMC (Hospital Equipment Manufacturing Company) (India).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com